Kriya Therapeutics, Inc.

📍 Palo Alto, United States🗓 Founded 2019👥 195 employees💰 Last funded 2024
Biotechnology Research🌐 kriyatx.com
Website LinkedIn
Kriya Therapeutics, Inc. is a biopharmaceutical company developing gene therapies for diseases affecting millions of people around the world. With operations in Palo Alto, California and Research Triangle Park, North Carolina, Kriya has raised over $450 million to advance a broad pipeline of gene therapies for ophthalmology, neurology, and metabolic diseases.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2019–2024 · investors recorded per year
20191202012021120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Kriya Therapeutics, Inc.?
Kriya Therapeutics, Inc. has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Kriya Therapeutics, Inc. last raise funding?
The most recent investment in Kriya Therapeutics, Inc. recorded on gritt.io was in 2024.
When was Kriya Therapeutics, Inc. founded?
Kriya Therapeutics, Inc. was founded in 2019.
What industry is Kriya Therapeutics, Inc. in?
Kriya Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kriya Therapeutics, Inc. based?
Kriya Therapeutics, Inc. is headquartered in Palo Alto, United States.